Aligos Therapeutics
ALGS
ALGS
59 hedge funds and large institutions have $36M invested in Aligos Therapeutics in 2022 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 9 increasing their positions, 20 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
47% less capital invested
Capital invested by funds: $68.4M → $36M (-$32.3M)
55% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 20
Holders
59
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.87M | |
| 2 | +$1.16M | |
| 3 | +$654K | |
| 4 |
Millennium Management
New York
|
+$562K |
| 5 |
NYLIM
New York Life Investment Management
New York
|
+$262K |
Top Sellers
| 1 | -$3.7M | |
| 2 | -$3.17M | |
| 3 | -$1.3M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.01M |
| 5 |
State Street
Boston,
Massachusetts
|
-$418K |